Researchers
Erik Škof
Assist. Prof. Erik Škof, MD, PhD
SICRIS No.: 24572
ORCID iD: 0000-0001-7076-4186
E-mail: eskof(at)onko-i.si
Phone: +3861 5879 284
Assist. Prof. Erik Škof, MD, PhD, specialist in internal medicine and medical oncologist, graduated at the Medical faculty, University of Ljubljana, Slovenia in 1998. He had obtained Msc degree in 2022 and PhD degree in 2011 at Medical faculty, University of Ljubljana, Slovenia. Dr. Škof is employed at the Institute of Oncology Ljubljana as medical oncologist since 2005. Initially he was involved in systemic treatment of gastrointestinal and breast cancer patients, since 2013 he is dedicated to systemic treatment of gynaecologic cancers. His bibliography covers latest Slovenian clinical recommendations and extensive research work in different gynaecologic cancer types. He is a member of many european cancer societies - European society for medical oncology (ESMO), European society for gynaecologic oncology (ESGO) and Central and Eastern European Gynacologic Oncology Group (CEEGOG).
My latest bibliography:
1. JANŽIČ, Urška, JANŽIČ, Andrej, AGBARYA, Abed, BIDOVEC, Urška, MOHORČIČ, Katja, ČAKŠ, Marina, KOROŠEC, Peter, RIJAVEC, Matija, ŠKOF, Erik. Prospective observational study of COVID-19 vaccination in patients with thoracic malignancies : adverse events, breakthrough infections and survival outcomes. Biomedicines. [Online ed.]. 2024, vol. 12, str. 535-1-535-12, ilustr. ISSN 2227-9059. www.mdpi.com/2227-9059/12/3/535, DOI: 10.3390/biomedicines12030535. [COBISS.SI-ID 189077251], [Odprti dostop, JCR, SNIP, WoS, Scopus]
2. ŠKOF, Erik, STEGEL, Vida, ŠETRAJČIČ DRAGOŠ, Vita, BLATNIK, Ana, GREGORIČ, Brigita, ŠKERL, Petra, KLANČAR, Gašper, ZAGOŽEN KLASINC, Anja, BOMBAČ, Alenka, KRAJC, Mateja, NOVAKOVIĆ, Srdjan. Exploring the impact of BRCA1 and BRCA2 mutation type and location on olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer patients : a single center report. Gynecologic oncology. [Print ed.]. 2024, vol. 190, no. , str. 104-112. ISSN 0090-8258. DOI: 10.1016/j.ygyno.2024.08.012. [COBISS.SI-ID 205458179], [JCR, SNIP, WoS, Scopus]
3. BLATNIK, Ana, ŠETRAJČIČ DRAGOŠ, Vita, BLATNIK, Olga, STEGEL, Vida, KLANČAR, Gašper, NOVAKOVIĆ, Srdjan, DREV, Primož, ŽAGAR, Tina, MERLO, Sebastjan, ŠKOF, Erik, PAVLOVA BOJADŽISKI, Mirjana, STROJNIK, Ksenija, KRAJC, Mateja. A population-based study of patients with small cell carcinoma of the ovary, hypercalcemic type, encompassing a 30-year period. Archives of pathology & Laboratory Medicine. Jun. 2023, vol. 147, iss. 6, str. [1-10]. ISSN 0003-9985. DOI: 10.5858/arpa.2022-0297-OA. [COBISS.SI-ID 154465283], [JCR, SNIP, Scopus do 29. 11. 2024: št. citatov (TC): 3, čistih citatov (CI): 3, čistih citatov na avtorja (CIAu): 0.27]
4. MICESKA, Simona, ŠKOF, Erik, NOVAKOVIĆ, Srdjan, STEGEL, Vida, JERIČEVIĆ, Anja, GRČAR-KUZMANOV, Biljana, SMRKOLJ, Špela, CVJETIČANIN, Branko, BEBAR, Sonja, GLOBOČNIK KUKOVICA, Marta, KLOBOVES-PREVODNIK, Veronika. Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites. Cancer cytopathology. [Print ed.]. Mar. 2023, vol. 131, iss. 3, str. 188-197, ilustr. ISSN 1934-662X. acsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/cncy.22664, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1002/cncy.22664. [COBISS.SI-ID 131704067], [JCR, SNIP, WoS do 7. 12. 2024: št. citatov (TC): 6, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.10, Scopus do 31. 8. 2024: št. citatov (TC): 5, čistih citatov (CI): 0, čistih citatov na avtorja (CIAu): 0.00]
5. CVIIČ, Diana, JAGARLAMUDI, K. K., MEGLIČ, Leon, ŠKOF, Erik, ZORE, Andrej, LUKANOVIČ, David, ERIKSSON, Staffan, OSREDKAR, Joško. A dual biomarker TK1 protein and CA125 or HE4-based algorithm as a better diagnostic tool than ROMA Index in early detection of ovarian cancer. Cancers. 2023, vol. 15, iss. 5, art. 1593, 18 str., ilustr. ISSN 2072-6694. www.mdpi.com/2072-6694/15/5/1593, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.3390/cancers15051593. [COBISS.SI-ID 144061955], [Odprti dostop, JCR, SNIP, WoS do 3. 1. 2025: št. citatov (TC): 6, čistih citatov (CI): 6, čistih citatov na avtorja (CIAu): 0.75, Scopus do 29. 12. 2024: št. citatov (TC): 8, čistih citatov (CI): 8, čistih citatov na avtorja (CIAu): 1.00]
projekt: 20190069 Tertiary Research Project
6. MICESKA, Simona, ŠKOF, Erik, GAŠLJEVIĆ, Gorana, KLOBOVES-PREVODNIK, Veronika. Morphological and immunocytochemical characterization of tumor spheroids in ascites from high-grade serous carcinoma. Cells. 2023, vol. 12, no. 19, [article no.] 2390, str. 1-14. ISSN 2073-4409. www.mdpi.com/2073-4409/12/19/2390, Digitalna knjižnica Univerze v Mariboru – DKUM, DOI: 10.3390/cells12192390. [COBISS.SI-ID 167619075], [JCR, SNIP, WoS do 31. 8. 2024: št. citatov (TC): 2, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.25, Scopus do 7. 5. 2024: št. citatov (TC): 2, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.25]
7. OSREDKAR, Joško, JAGARLAMUDI, K. K., CVIIČ, Diana, ŠKOF, Erik, CVJETIČANIN, Branko, ZORE, Andrej, LUKANOVIČ, David, ERIKSSON, Staffan, MEGLIČ, Leon. Clinical significance of the TK1 specific activity in the early detection of ovarian cancer. Oncology. 2024, vol. 102, no 1, str. 17-29, ilustr. ISSN 1423-0232. karger.com/ocl/article-abstract/102/1/17/862519/Clinical-Significance-of-the-TK1-Specific-Activity, DOI: 10.1159/000533428. [COBISS.SI-ID 163920899], [JCR, SNIP, WoS do 9. 10. 2024: št. citatov (TC): 2, čistih citatov (CI): 2, čistih citatov na avtorja (CIAu): 0.22, Scopus do 9. 10. 2024: št. citatov (TC): 1, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.11]
8. MICESKA, Simona, ŠKOF, Erik, BUČEK, Simon, GRAŠIČ-KUHAR, Cvetka, GAŠLJEVIĆ, Gorana, SMRKOLJ, Špela, KLOBOVES-PREVODNIK, Veronika. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma. Radiology and oncology. [Print ed.]. 2023, vol. 57, no. 4, str. 493-506. ISSN 1318-2099. pubmed.ncbi.nlm.nih.gov/38038414/, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, Digitalna knjižnica Slovenije - dLib.si, DOI: 10.2478/raon-2023-0046. [COBISS.SI-ID 174791427], [JCR, SNIP, WoS do 5. 12. 2024: št. citatov (TC): 3, čistih citatov (CI): 2, čistih citatov na avtorja (CIAu): 0.29, Scopus do 16. 12. 2024: št. citatov (TC): 4, čistih citatov (CI): 2, čistih citatov na avtorja (CIAu): 0.29]
9. JANŽIČ, Urška, BIDOVEC, Urška, KOROŠEC, Peter, MOHORČIČ, Katja, MRAK, Loredana, ČAKŠ, Marina, RAVNIK, Maja, ŠKOF, Erik, RIJAVEC, Matija. A three-dose mRNA COVID-19 vaccine regime produces both suitable immunogenicity and satisfactory efficacy in patients with solid cancers. Vaccines. 2023, vol. 11, iss. 6, str. 1-12. ISSN 2076-393X. www.mdpi.com/2076-393X/11/6/1017, DOI: 10.3390/vaccines11061017. [COBISS.SI-ID 153238275], [JCR, SNIP, WoS do 5. 4. 2024: št. citatov (TC): 2, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.11, Scopus do 4. 4. 2024: št. citatov (TC): 2, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 0.11]
10. STEGEL, Vida, BLATNIK, Ana, ŠKOF, Erik, ŠETRAJČIČ DRAGOŠ, Vita, KRAJC, Mateja, GREGORČIČ, Brigita, ŠKERL, Petra, STROJNIK, Ksenija, KLANČAR, Gašper, BANJAC, Marta, ŽGAJNAR, Janez, RAVNIK-OBLAK, Maja, NOVAKOVIĆ, Srdjan. Real-world data on detection of germline and somatic pathogenic/likely pathogenic variants in BRCA1/2 and other susceptibility genes in ovarian cancer patients using next generation sequencing. Cancers. Mar. 2022, vol. 14, no. 6, str. 1434-1-1434-17. ISSN 2072-6694. www.mdpi.com/2072-6694/14/6/1434, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3390/cancers14061434. [COBISS.SI-ID 100563715], [Odprti dostop, JCR, SNIP, WoS do 2. 1. 2025: št. citatov (TC): 9, čistih citatov (CI): 6, čistih citatov na avtorja (CIAu): 0.54, Scopus do 30. 12. 2024: št. citatov (TC): 8, čistih citatov (CI): 5, čistih citatov na avtorja (CIAu): 0.45]
11. JANŽIČ, Urška (avtor, korespondenčni avtor), BIDOVEC, Urška, MOHORČIČ, Katja, MRAK, Loredana, FOKTER DOVNIK, Nina, IVANOVIĆ, Marija, RAVNIK, Maja, ČAKŠ, Marina, ŠKOF, Erik, DEBELJAK, Jerneja, KOROŠEC, Peter, RIJAVEC, Matija. Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination. Future oncology. 2022, vol. 18, no. 23, str. 2537–2550. ISSN 1479-6694. DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.2217/fon-2022-0148. [COBISS.SI-ID 111378179], [JCR, SNIP, WoS do 15. 9. 2024: št. citatov (TC): 5, čistih citatov (CI): 3, čistih citatov na avtorja (CIAu): 0.28, Scopus do 16. 9. 2024: št. citatov (TC): 5, čistih citatov (CI): 3, čistih citatov na avtorja (CIAu): 0.28]
12. POVEDA, Andres (avtor, korespondenčni avtor), LHEUREUX, S., COLOMBO, Nicoletta, CIBULA, David, LINDEMANN, Kristina, WEBERPALS, Janick, BJURBERG, M., OAKNIN, A., MADRY, Radoslaw, ŠKOF, Erik, et al. Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation : OPINION primary analysis. Gynecologic oncology. [Print ed.]. 2022, vol. 164, iss. 3, str. 498-504, ilustr. ISSN 0090-8258. www.gynecologiconcology-online.net/article/S0090-8258(21)01693-0/fulltext, DOI: 10.1016/j.ygyno.2021.12.025. [COBISS.SI-ID 94619395], [JCR, SNIP, WoS do 4. 2. 2025: št. citatov (TC): 28, čistih citatov (CI): 28, čistih citatov na avtorja (CIAu): 2.23, Scopus do 26. 1. 2025: št. citatov (TC): 29, čistih citatov (CI): 29, čistih citatov na avtorja (CIAu): 2.31]
13. KOVAČEVIĆ, Nina, ŠKOF, Erik, CILENŠEK, Ines, MERLO, Sebastjan. Management of advanced staged ovarian cancer in a national cancer center : comparison of the efficacy of primary debulking surgery versus neoadjuvant chemotherapy. Current women's health reviews. 2021, vol. 17, iss. 3, str. 267-273. ISSN 1573-4048. DOI: 10.2174/1573404817666210106093301. [COBISS.SI-ID 41262595], [SNIP, WoS, Scopus]
14. ŠKOF, Erik. Izkušnje z zdravilom olaparib pri zdravljenju recidivnega epitelijskega raka jajčnikov z mutacijami v genih BRCA 1 in BRCA 2 = Experience with olaparib in the treatment of recurrent ovarian epithelial cancer with mutations in the BRCA 1 and BRCA 2 genes. Onkologija. [Tiskana izd.]. jun. 2021, leto. 25, št. 1, str. 12-16. ISSN 1408-1741. Digitalna knjižnica Slovenije - dLib.si, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.25670/oi2021-002on. [COBISS.SI-ID 65264899], [WoS do 31. 12. 2023: št. citatov (TC): 1, čistih citatov (CI): 1, čistih citatov na avtorja (CIAu): 1.00]